
AdvanSix Inc. (ASIX) Market Cap
AdvanSix Inc. has a market capitalization of $540.8M.
Price: $20.06
βΌ -0.54 (-2.62%)
Market Cap: 540.80M
NYSE Β· time unavailable
CEO: Erin N. Kane
Sector: Basic Materials
Industry: Chemicals - Specialty
IPO Date: 2016-09-15
Website: https://www.advansix.com
AdvanSix Inc. (ASIX) - Company Information
Market Cap: 540.80M|Sector: Basic Materials
Company Profile
AdvanSix Inc. operates as a global manufacturer and supplier of polymer resins, serving markets across the United States and internationally. A key offering is Nylon 6, a versatile synthetic polymer resin utilized in the production of fibers, filaments, specialized plastics, and films. The company's portfolio also includes caprolactam, an essential building block for other polymer resins, and ammonium sulfate fertilizers, which it distributes to farm cooperatives, retailers, and other channel partners. Furthermore, AdvanSix supplies acetone, a crucial ingredient for manufacturing adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins. Its extensive range additionally comprises various intermediate chemicals, such as phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. These offerings are marketed under established brands like Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox. AdvanSix utilizes a dual sales approach, engaging directly with customers while also leveraging a network of distributors. The company, established in 2016, is headquartered in Parsippany, New Jersey.
Analyst Sentiment
From 2 Active Polls
1Y Forecast: $25.00
β² +24.6% Potential Upside
Consensus Target Metrics
Low Bound
$25
Median
$25
High Bound
$25
Average
$25
Price & Moving Averages
π― Wall Street Analyst Intelligence Report
1-Year structural target targets, chart projections, and sentiment maps.
Consensus Trend Projection
Trailing closures vs. 12-month metrics map.
Analyst Vote Distribution
Aggregate institutional coverage sentiment weights.
π Historical Valuation Multiples
Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.
| Fiscal Quarter | TTM | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Trailing 12M | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
| Market Cap ($M) | 541 | 658 | 466 | 521 | 638 | 608 | 764 | 814 | 592 |
| Enterprise Value ($M) | 950 | 1,067 | 829 | 904 | 997 | 960 | 1,093 | 1,103 | 902 |
| Price to Earnings Ratio (P/E) | 51.44 | -10.52 | -43.25 | -48.45 | 5.07 | 6.51 | 543.70 | 9.15 | 3.81 |
| Price/Earnings-to-Growth Ratio (PEG) | β | -0.86 | β | β | 0.59 | 0.44 | β | β | 0.11 |
| Price to Sales Ratio (P/S) | 0.35 | 1.63 | 1.29 | 1.39 | 1.56 | 1.61 | 2.32 | 2.04 | 1.31 |
| Price to Book Ratio (P/B) | 0.68 | 0.83 | 0.57 | 0.64 | 0.77 | 0.77 | 0.99 | 1.06 | 0.79 |
| Price to Free Cash Flow Ratio (P/FCF) | -24.33 | -12.84 | 12.90 | 7895.14 | -89.18 | -26.87 | 25.61 | 30.42 | 35.46 |
| Enterprise Value to Sales (EV/Sales) | β | 2.64 | 2.30 | 2.41 | 2.43 | 2.54 | 3.32 | 2.77 | 1.99 |
| Enterprise Value to EBITDA (EV/EBITDA) | 9.92 | 393.62 | 40.37 | 47.33 | 18.69 | 19.34 | 131.24 | 21.37 | 12.07 |
| Debt to Equity Ratio | 4.27 | 0.54 | 0.47 | 0.50 | 0.46 | 0.45 | 0.45 | 0.40 | 0.43 |
π° Market News & Coverage
15 Stories AvailableReal-time institutional reporting and market updates for ASIX.
Related Companies in Basic Materials

OLYMPIC STEEL INC (ZEUS)
Basic Materials
$0.54B
Mkt Cap

CRITICAL METALS CORP (CRML)
Basic Materials
$0.51B
Mkt Cap

FERROGLOBE PLC (GSM)
Basic Materials
$0.59B
Mkt Cap

MATIV HOLDINGS INC (MATV)
Basic Materials
$0.48B
Mkt Cap

RAYONIER ADVANCED MATERIALS INC (RYAM)
Basic Materials
$0.60B
Mkt Cap

DAKOTA GOLD CORP (DC)
Basic Materials
$0.61B
Mkt Cap
π AI Financial Analysis
Powered by StockMarketInfo"ASIX reported Q1β26 revenue of $404.2M and net income of -$15.5M (EPS -$0.58). Revenue declined QoQ (from $359.9M in Q4β25 to $404.2M in Q1β26, +12.3%), but swung to losses sequentially: net income moved from -$2.8M in Q4β25 to -$15.5M in Q1β26 (worsened by -456%). YoY, revenue decreased from $377.8M in Q1β25 to $404.2M in Q1β26 (+7.0%), while net income deteriorated from +$23.3M in Q1β25 to -$15.5M in Q1β26 (down -166.6%). Profitability deteriorated materially: Q1β26 net margin was -3.85% versus -0.78% in Q4β25 and +6.18% in Q1β25. Operating income also fell to -$0.5M from +$2.2M in Q4β25, with EBITDA turning negative (-$0.5M). Cash flow quality weakenedβoperating cash flow was -$15.3M and free cash flow was -$15.3M in Q1β26, after positive OCF in Q4β25 (+$63.7M) and Q2β25 (+$21.1M). Balance sheet resilience is mixed: equity increased to ~$796.3M, but net debt remains high (~$408.8M) and liquidity is tight (cash $17.6M). Shareholder returns: the stock price was $21.57 with only +8.17% 1y momentum, so total shareholder return is not being boosted by strong price momentum. Dividend yield is low (~0.66%) and buybacks appear limited (none reported in Q1). Analyst valuation consensus ($22) is close to market."
Revenue Growth
Q1β26 revenue was $404.2M: +12.3% QoQ (vs $359.9M in Q4β25) and +7.0% YoY (vs $377.8M in Q1β25). Growth is positive, but not translating into earnings.
Profitability
Margins sharply contracted: net margin -3.85% in Q1β26 vs -0.78% in Q4β25 and +6.18% in Q1β25. Net income fell from +$23.4M (Q1β25) to -$15.5M (Q1β26) (-166.6% YoY) and from -$2.8M (Q4β25) to -$15.5M (QoQ, worse by -456%).
Cash Flow Quality
Q1β26 operating cash flow was -$15.3M and free cash flow -$15.3M, reversing prior strength (Q4β25 OCF +$63.7M). This indicates weaker cash generation alongside losses.
Leverage & Balance Sheet
Equity is stable-to-higher at ~$796.3M, but leverage remains meaningful with net debt of ~$408.8M. Liquidity is thin (cash ~$17.6M) and the quick ratio is <1.
Shareholder Returns
Total return support appears limited: 1y price change is +8.17% (below the >20% threshold). Dividend yield is low (~0.66%), and no buybacks are reported in Q1β26.
Analyst Sentiment & Valuation
Consensus target is $22 vs price $21.57 (roughly in-line). Sentiment seems neutral rather than aggressively bullish given the recent earnings deterioration.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.
Fundamentals Overview
AdvanSix delivered ~7% YoY sales growth in Q1 2026, led by ~6% volume and ~1% favorable pricing, but profitability deteriorated sharply. Adjusted EBITDA was $5 million, down $47 million YoY, driven primarily by the absence of $20 million prior-year insurance proceeds plus margin pressure from higher sulfur and natural gas costs, higher utilities, and $11 million winter-storm impacts. Management stressed that Q1 did not fully recover inflationary inputs through formula/index pass-through, but expects to recoup a large portion in Q2 during the domestic planting season. The company also highlighted extremely elevated sulfur conditionsβ$655/long ton record level in 2026 and currently higher spotβwhile noting pricing remains contract-based for sulfur purchases. Strategically, the DEF expansion at the Hopewell, Virginia ammonia platform is a clear growth catalyst, targeting a 2027 FID and 2029 startup, with management positioning it as fitting their 20%+ IRR hurdle discipline. 45Q credits appear to remain a meaningful near-term cash driver, with ~$18 million expected in 2H.
Growth Catalysts
- Sequential earnings/cash flow improvement expected into Q2 as plant nutrients season progresses and operational performance improves
- Recouping Q1 raw-material cost shortfall via pass-through formula and freely negotiated pricing mechanisms, particularly into the heart of the domestic planting season
- Potential value unlock from integrated ammonia platform expansion to domestically manufacture DEF (final investment decision targeted for 2027; operational startup targeted for 2029)
- Tightening acetone supply/demand environment supporting full-year 2026 expectations for acetone spreads near cycle averages
Business Development
- Process design and licensing agreement to expand Hopewell, Virginia integrated ammonia platform to enable domestic manufacturing of DEF (EPA-mandated additive for diesel NOx reduction)
- DEF commercialization framed around supplying a Mid-Atlantic/Northeast-driven market currently served by imports and production from other domestic regions
- High-return growth/cost savings alignment to internal 20%+ IRR hurdle rates (applied by management to this DEF project and other programs)
Financial Highlights
- Sales increased ~7% YoY: ~6% volume growth and ~1% favorable price
- Adjusted EBITDA was $5 million, down $47 million YoY (driven by absence of $20 million insurance proceeds in prior year, higher sulfur and natural gas prices, higher utility expenses, and $11 million winter-storm-related impacts)
- Raw material pass-through pricing down 2% YoY (net cost decrease in benzene/propylene affecting cumene feedstock)
- Market-based pricing improved 3% YoY (plant nutrients higher nitrogen pricing amid increased sulfur input costs)
- Q1 seasonality: first quarter represents expected seasonal cash use due to CapEx payment timing after prior-quarter outages
- Management expects Q2 sequential improvement and second half cash generation to meet full-year expectations
Capital Funding
- Full-year CapEx expected at $75 million to $95 million, with nearly 20% targeted toward high-return growth investments
- Debt leverage expected near the low end of 1.0x to 2.5x by year-end
- 45Q carbon capture credits: audit for 2018β2020 credit underway; cash expected to be another ~$18 million in the second half (after $2 million received previously, with $20 million total value for that period)
Strategy & Ops
- Winter-storm impact managed with safe operations; earnings impact slightly above high end of anticipated range; $3 million of planned turnaround expense saved for the year
- Cost productivity and turnaround execution emphasis; continued working capital discipline
- Risk-based prioritization of capital investments and controllable levers including non-manpower fixed cost savings program
- DEF project: FEED/process design and licensing underway; management stated no ammonia expansion required for DEF (marginal ammonia debottlenecking considered generally, but not needed for this project)
- Nylon/acetone agility actions: reducing nylon resin inventory to align with market conditions; evaluating export opportunities to maximize economics within integrated enterprise
Market Outlook
- Domestic granular fertilizer sales for the year now expected near record levels but closer to flat vs last year
- Management cited sulfur pricing: record $655 per long ton in 2026, with current spot trading even higher; stated this is >30% sequential increase and ~140% YoY
- Management guided expectation that spot prices remain higher than Q2 settlement; described pricing staying higher for longer with Q3 settlement coming in βa couple of monthsβ
- Acetone: spreads expected to hold near cycle averages for full-year 2026
Risks & Headwinds
- Winter-storm-related impacts: $11 million in Q1 and earnings impact slightly above high end of anticipated range
- Raw material inflation: higher sulfur and natural gas driving margin pressure; Q1 did not fully cover costs via pass-through/index mechanisms
- Utility expense pressure contributing to EBITDA decline
- Subdued industrial end-market demand and cautious buying downstream amid higher input costs and rapidly rising nitrogen prices
- Fertilizer fundamentals: farmer profitability and input affordability challenged; cold weather early spring and drought conditions increased caution in purchasing behavior
- Acetone/phenol demand softness and soft nylon demand in certain segments (e.g., carpet applications) affecting volumes
Q&A: Analyst Interest
- Topic: DEF ammonia project capital intensity and hurdle rate. Management said CapEx would be larger than the Sustain program, but specific ranges were kept confidential during FEED and vendor negotiations. They reiterated internal high-return targets of 20%+ IRR hurdle rates as appropriate for this programβs profile.
- Topic: Sulfur pricing persistence and contract vs spot dynamics. Management stated spot sulfur continues to trade above the Q2 settlement and suggested pricing likely stays higher for longer even if Middle East conflict resolves quickly. They emphasized timing uncertainty, demand sensitivity in phosphate fertilizer (~50% of world sulfur usage), and contract-based purchasing.
- Topic: 45Q credit timing and remaining tranches. Management described an IRS audit for 2018β2020 credits with field work expected to wrap in Q2 and audit progress ongoing. They noted $20 million total value with $2 million already received and another ~$18 million expected in 2H, plus submitted 2021 lifecycle assessments to DOE/IRS.
Sentiment: MIXED
Note: This summary was synthesized by AI from the ASIX Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.
π Official Regulatory 10-K / 10-Q SEC Filings
Direct authenticated documentation links to audited SEC database reports for ASIX.














